Class I Recall Expanded for Alaris Pump Infusion Sets
The voluntary recall involves certain infusion sets used with the BD Alaris Pump Module model 8100 due to performance deviations that could impact dose accuracy.
The voluntary recall involves certain infusion sets used with the BD Alaris Pump Module model 8100 due to performance deviations that could impact dose accuracy.
The newly cleared platform combines MR and ultrasound imaging to support real-time guidance for focal therapy and improve clinical accuracy.
New white paper highlights the need to secure operational technologies used in medical product production.
The voluntary recall involves certain infusion sets used with the BD Alaris Pump Module model 8100 due to performance deviations that could impact dose accuracy.
Changes in suppliers and manufacturing locations to avoid tariffs can require new regulatory filings, increasing time and cost burdens across global markets.
Read MoreA former FDA official argues that medical device repair needs stricter oversight to protect patient safety amid growing right to repair efforts.
Read MoreThe FDA has issued a warning letter to ICU Medical, citing regulatory violations related to unapproved modifications to two of its infusion pumps.
Read MoreAAMI has named the advisory council and selected a venue for its 2026 medical device standards-focused conference.
Read MoreNew framework calls for clear regulatory pathways, data access reform, and reimbursement strategies to advance AI-enabled medical devices.
Read MoreIn a blind review, scans performed by novices using the software met diagnostic standards and matched expert-level quality.
Read MoreAsking the right questions helps ensure quality service, control costs, support compliance, and avoid surprise charges or service gaps.